Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
  Phillip Investor Notes

06-04-2020(Mon) 03-04-2020(Fri) 02-04-2020(Thu) 01-04-2020(Wed) 31-03-2020(Tue)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
30 Aug, 2019 (Friday)

CPMC Holdings (906) is principally engaged in the manufacturing and sale of packaging products used for consumer goods such as food, beverages and household chemical products, extensively covering the packaging markets of beer, carbonated beverages, dairy products, tea beverages, fruit and vegetable beverages, food, household chemical products and other consumer goods. For the six months ended 30 June 2019, operating revenue of the Group reached approximately RMB3.68 billion, representing an increase of approximately 10.4% over the same period last year. Profit attributable to shareholders amounted to RMB170 million, representing an increase of approximately 18.8% over the same period last year, mainly attributable to the growth in its two-piece cans business. The Group will continue to steadily push forward the production capacity expansion at home and abroad, including Fujian Canmaking`s second production line project and the Belgium two-piece can project. (I do not hold the above stock)
Buy-in Price: $3.15, Target Price: $3.45, Cut Loss Price: $3.00

It is the leading enterprise in the field of isotopes and irradiation technology applications in China. In 2017, it is the largest manufacturer of imaging diagnostic and therapeutic radiopharmaceuticals, UBT kits and analyzers and radioactive source products, respectively, in terms of revenue in China. Its business can be categorize into four sectors as pharmaceuticals, radioactive source products, irradiation, independent clinical laboratory services and other business. The company`s annual revenue last year increased by 21.2% y.o.y. to RMB3.238 billion, and net profit increased 19% y.o.y. to RMB323 million. The medical application of isotopes in China primarily includes the imaging diagnostic and therapeutic radiopharmaceuticals, UBT kits and analyzers, RIA kits and medical radioactive source products. PRC isotopes medical application market reached RMB 4382.0 million in 2017, growing at a CAGR of 12.1% during 2013 to 2017, and is expected to grow to RMB 10634.1 million in 2022, with a CAGR of 19.4%.
Buy-in Price: $19.24, Target Price: $23.00, Cut Loss Price: $15.00

Want Want China (151.HK) - Product mix optimization continuing, expand emerging channels and digital marketing

Investment Summary

Want Want's revenue of FY 2018 increased by 2.8% y.o.y. Under the original accounting standards, revenue increased by mid-single digit. The ASP of the year also increased by mid-single digit, which means that the sales volume growth was flat. According to the management team, sales performance of Q1 in FY2019 was flat on y.o.y. basis due to the large base effect. Compared to the same period of 2017, it recorded a mid-single digit growth.

We expect revenue of FY2019 can remind a stable growth with the consideration of that the company will launch a number of new products this year and is expected to account for 2.5% to 3% of the total revenue. The company will also continue to expand emerging channels such as maternity, cold chain, vending machines and Hot-Kid theme stores. We expect this year's growth is mainly driven by sales volume. This year's new products include ¡§Mr. Bond¡¨ series, ¡§Queen Alice¡¨ series which aim to attract stylish urban ladies.

The GPM of FY2018 increased by 2.7 ppt. to 45.4%, thanked to the decrease in cost of certain key raw materials and the enhancement of product profitability. We expect the GPM of FY2019 to be further improve as the cost of certain key raw materials such as milk powder and packaging materials continue to decline, and the trend is expected to continue in the next two quarters, coupled with continued enhancement of profit profitability.

The operation cost of FY2018 increased by 4% y.o.y., while the proportion to revenue was 25.7%, which was similar to the previous year. The increase in management fees was due to the increase in staff salaries. The management team expect there will be an increase of advertising expenses in distribution expenses which will be invest mainly in emerging channels and new products.

Revenue from traditional channel shared 78% of the total revenue in FY2018, whereas e-commerce platform shared 4.5%, modern channels shared 11%, overseas market shared 5%. We expect that all channels will maintain the growth trend this year, and the e-commerce platform will continue to maintain rapid growth.

After the cross-sector co-branding activities between Want Want and brands in the fashion and apparel and beauty sectors, in April 2019, there was ¡§Want at home¡¨ programme, which was the idea of launching furniture products such as Hot-Kid ball cakes couch and Want Want sugarcoated crackers table lamp. Soon after, the announcement regarding the ¡§Hot-Kid seasoning¡¨ (such as savoury senbei powder and condensed milk) received over 200 million impressions. Netizens showed great interest and all are looking forward to the official launch of those products. We give forecast P/E ratio 21 times, the corresponding target price HKD6.71. (current price as of August 28, 2019)

Business Overview

Financial performance review of FY2018

In 2018FY, the total revenue amounted to RMB20,712.0 million, representing an increase of 2.8% as compared with that of 2017FY. Profit attributable to equity holders of the Company for 2018FY amounted to RMB3,476.6 million, representing an increase of 11.6%.

Revenue from rice crackers and snack foods segments was RMB5,813.5 million and RMB5,101.1 million respectively, representing a respective increase of 3.9% and 3.5% as compared with that of FY2017. The aggregate revenue from rice crackers and snack foods segments accounted for 52.7% of the total revenue.

According to the management team, with the development of overseas markets, rice crackers products with local characteristics will be launched in the future for each targeted market. Revenue from dairy products and beverages segment increased by 1.6% as compared with that of FY2017, amounted to RMB9,729.6 million and accounted for 47.0% of the total revenue.

Investment Thesis & Valuation

We give forecast P/E ratio 21 times, the corresponding target price HKD6.71. Potential investment risks include revenue growth or channel expansion missing expectation, raw material cost with huge volatility. (current price as of August 28, 2019)


Click Here for PDF format...

Recommendation on 30-8-2019
Price on Recommendation Date$ 5.970
Suggested purchase priceN/A
Target Price$ 6.710
Writer Info
Tracy Ku
(Research Analyst)
Tel: +852 2277 6516

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%

A-H spread
Stock Code H share
A share
H share

Oversea Research Reports

Investment Service Centre

Enquiry : 2277 6666 OR
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2019 Phillip Securities (HK) Ltd. All Rights Reserved.

Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]